-
Expanding globally in the AI image based diagnosis sector, Diagnos is actively commercializing their CARA technology
CARA’s Artificial Intelligence image enhancement algorithms make standard retinal images sharper, clearer and easier to read. CARA is…
-
Warrant Exercise Builds Treasury for Perimeter’s 2021 Commercialization Efforts
Last week, Perimeter Medical Imaging AI, Inc. (TSXV: PINK) announced that approximately 2.35 million warrants subject to an…
-
Nano One Performs Well in Solid State Battery Tests at the University of Michigan
Nano One Materials Corp. (TSXV: NNO) reported this week that its technology performed well in solid-state battery testing…
-
Revenue is forecast to triple, Valeo Pharma has 10 products in their portfolio
COVID-19 continues to be a huge global problem with global cases now over 112 million. Vaccines are a…
-
Valeo Pharma’s Steve Saviuk on Hesperidin and reducing the risk of securing COVID-19
In a new InvestorIntel interview Tracy Weslosky speaks with Steve Saviuk, CEO of Valeo Pharma Inc. (CSE: VPH…
-
Fully funded with strong IP Portfolio, Hemostemix marches forward towards FDA Phase II Clinical Trial Completion
Hemostemix Inc. (TSXV: HEM | OTC: HMTXF) continues to move forward with its FDA Phase II clinical trial…
